Filter
935
Filtered Results: 935
Text search:
pharmaceutical
regulatory
authority
Featured
Recommendations
77
New Publications
287
Language
Document type
No document type
483
Studies & Reports
169
Guidelines
140
Manuals
56
Strategic & Response Plan
51
Fact sheets
15
Training Material
9
Situation Updates
8
Resource Platforms
3
Brochures
1
Countries / Regions
Kenya
41
Ethiopia
39
India
32
Uganda
27
South Africa
24
Global
23
Liberia
21
Ghana
19
Rwanda
19
Nigeria
19
Tanzania
17
Sierra Leone
16
Zambia
16
Malawi
15
Bangladesh
15
Nepal
14
Western and Central Europe
14
Namibia
13
Ukraine
11
Zimbabwe
10
Syria
9
Cambodia
9
Myanmar / Burma
9
Lesotho
8
Philippines
8
Eastern Europe
8
Botswana
8
Africa
7
South–East Asia Region
6
West and Central Africa
5
Indonesia
5
Eswatini/ Swaziland
5
Latin America and the Carribbean
4
Congo, Democratic Republic of
4
Western Pacific Region
4
East and Southern Africa
4
Thailand
3
Benin
3
Albania
3
Burkina Faso
3
Guinea
3
Jordan
3
Middle East and North Africa
3
Eastern Europe and Central Asia
3
Pakistan
3
Cameroon
2
Laos
2
Senegal
2
Mozambique
2
USA
2
Haiti
2
Asia
2
United Kingdom
2
North Macedonia
1
Tajikistan
1
Timor Leste/ East Timor
1
Australia
1
Iran
1
Fiji
1
Afghanistan
1
Germany
1
Gabon
1
Turkmenistan
1
Denmark
1
Maldives
1
Lebanon
1
Vietnam
1
Papua New Guinea
1
Moldova
1
Russia
1
Egypt
1
Sudan
1
Central African Republic
1
Mali
1
Chad
1
Iraq
1
Somalia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Drugs & Medical Equipment
146
Policies
139
Guidelines
70
Studies & Reports
70
Policies & Guidelines HIV & TB
23
Community Health
18
COVID-19
17
Capacity Building
15
Statistics
15
Pediatrics
11
Health Systems
11
Paediatrics
10
Non-communicable Diseases
10
Laboratory Quality Assurance
10
Hepatitis
9
Waste Management
9
Women & Child Health
8
HIV & STI
7
Pharmacy & Technologies
7
TB
7
Infection Control & Prevention (IPC)
6
Pharmaceutical Assessments
6
General Guidelines
6
NTDs & Others
6
Maternal Health
6
Pharmacy & Technology
5
Disaster Preparedness
5
Cancer Treatment & Resources
5
Countries
5
Medical Devices & Equipment
5
Parasitology
5
Reproductive Health
5
Family Planning
4
Vaccine-preventable Diseases
4
Demograhic Health Surveys DHS
4
Immunization
4
Gynaecology & Obstetrics
4
Neonatal Care
4
Malaria
4
Disease Prevention & Control
4
Sanitation
3
Humanitarian Aid
3
Monitoring & Evaluation
3
Snakebites
3
Other
3
Needs Assessment
3
Primary Health Care
3
Water
3
Age & Elderly
3
Global Health
3
Medicines Donations
2
Rabies
2
Cancer
2
Laboratory Waste
2
Community Health
2
Palliative Care
2
Virology
2
Respiratory Infections
2
Quality Control & Assurance
2
Neurology & Psychology
2
Key Resources
2
Food Security & Nutrition
2
Communicable Diseases
1
Dental & Eye Care
1
Digital Health
1
Clinical Training
1
Emergency Health Kits
1
Child Health
1
Diabetes
1
Hand Hygiene
1
Bacteriology
1
Trachoma
1
Taeniasis/ Cysticercosis
1
Onchocerciasis
1
Schistosomiasis
1
Dermatology
1
Lymphaticfilariasis
1
x MEDBOX Issue Brief & Annual Reports x
1
General Guidelines
1
Vector Control
1
Public Health
1
Health System Strengthening
1
NCD
1
Cardiovascular Diseases
1
Hemorrhagic Fever
1
Yellow Fever
1
Information, Education and Communication (IEC)
1
Disabilities
1
Humanitarian Crisis
1
Palliative Care
1
Mental Health
1
WASH
1
Surgery & Anaesthesia
1
Leprosy
1
Women & Child Health
1
Hygiene Promotion
1
Toolboxes
Country specific
40
International
19
Rational use of Medicine
17
Waste Managment
16
Quality Assurance
15
Agriculture & Veterinary
12
Studies
12
Essential Medicines & Devices Lists
12
Pharmacy Practice
12
Influenza Prevention & Control
11
General
11
Essential Medicines
11
Falsified & Substandard
11
Supply Chain & Store Management
11
Traditional & Herbal Medicines
11
Pharmacovigilance
11
Eastern Europe and central Asia
10
Clinical Aspects, Treatment & Prevention
9
Public Health
9
Substance Use Disorders & Addiction
9
Country specific documents
8
Fair Allocation & Ethical Aspects
8
Reports & Studies
8
Antiretroviral Treatment ART
8
Reports & Studies
8
Supporting tools
7
Global Impact: Socio-economic, health services, TB & HIV
7
Waste Management
7
Assessment
7
Access & Strategy
6
Pharmacy Management
6
Key Resources
5
Policies
5
General Studies & Reports
5
Country Specific
5
Pharmaceutical Assessments
5
Antimicrobial Resistance (AMR)
5
Neurological Disorders
5
Surveillance
4
Substance Use Disorders, Others
4
Influenza
4
Opoids
4
Eastern Europe
4
Research
4
Climate & Health
4
Infection Control General
4
COVAX Initiative
4
Prices and Patents
4
General Information & Methodology
4
Drug resistant TB
4
Alzheimer's Disease & Dementia
4
Human Rights & the Right to Health
4
Disease Prevention & Control
4
Education of students & professionals
4
Stewardship
4
Neurological disorders, Others
4
Global Health Ethics
4
Assessment & Studies
3
Surveillance
3
Treatment & Prevention
3
Preparedness, Response & Risk Communication
3
Prevention & Control
3
Adults
3
Ukraine
3
Children
3
Prevention & Preparedness
3
Essential List
3
Surveillance & Contact tracing
3
Appeals and Response Plans
3
Essential Medicines & Medical Devices
3
Logistics & Supply
3
General documents One Health
3
Situation Reports & Updates
3
Guidelines & Manuals
3
Health Care In Conflict Settings
3
Overview, Studies & Reports
3
Health Financing Toolbox
3
Women
3
Detection & Diagnosis
3
Assessment & Response
3
TB & Prisoners
3
Research & Access
3
TB
3
Eastern Europe & Central Asia
3
SEAR (South-east Asia Region)
3
Drugs
2
Local Action
2
General Reports
2
Laboratory Guidance
2
Children & Adolescents
2
Policies & Programmes
2
General Mental Health Guidelines
2
Curricula & Core Competencies
2
TB
2
Children/Adolescents Mental Disorders
2
TB & Other Vulnerable Populations
2
Training
2
Reports
2
Cannabis
2
Universal Health Coverage UHC and 90-90-90 Strategy
2
Health Personnel
2
Livestock production
2
Diagnostics & Laboratory Guidance
2
Educational Settings
2
Physical Distancing
2
Communication Material
2
Immunization Guidelines
2
Preparedness, Response & Risk Communication
2
Health Promotion
2
Climate Change General
2
Model Formulary
2
Medicine Donations
2
Standard Operating Procedures (SOPs)
2
One Health
2
General Guidelines for Rational Use
2
Mental Disorders
2
Health Care Systems
2
Others
2
WASH Water Sanitation & Hygiene
2
Health Impact & Climate Change
2
Studies & Reports
2
Snakebite envenoming
2
Access to treatment and laboratory
2
General Information
2
Prevention & Strategies
2
Prevention & Strategies
2
Co-Morbidities (except TB)
2
Roadmaps, Action Plans & Policies
2
Vision Loss & Blindness
2
Zika Prevention & Control
2
Tobacco
2
Global Health Institutions and Stakeholders
2
Western & Central Europe
2
Infection Control
2
Lobby and Advocacy
2
Global Health Financing
2
Kenya
2
Social Determinants of Health
2
Capacity Building
2
Preparedness & Prevention
2
War & Conflict
1
Rapid Response
1
Alcohol
1
Cocaine
1
Psychosocial Support (MHPSS)
1
ART Drug Resistance
1
Clinical Guidelines
1
Meningitis Prevention & Control
1
Male Circumcision
1
Childhood TB
1
HIV testing & services
1
IPC
1
Moldova
1
Training
1
Azerbaijan
1
Background PTSD in children
1
Yellow Fever
1
Clinical Aspects
1
Yellow Fever Prevention & Control
1
Pediatrics
1
Opportunistic Infections
1
WASH
1
Prevention Guidelines
1
Interculturality
1
Context, Facts & Travel Advice
1
HIV testing & disclosure
1
Clinical Guidelines
1
Public Health
1
Hepatitis
1
Treatment Guidelines HIV
1
Concepts of Global Health
1
Diverse Chemical Substances
1
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
1
Mental Health
1
Tools for Rational use
1
People who injecting Drugs
1
Prophylaxis
1
Ebola & Marburg
1
Vaccination
1
Preparedness, Response & Risk Communication
1
Health & Refugee
1
Syria
1
Human Rights
1
Workplace
1
HIV / AIDS
1
Ethiopia
1
IEC Substance Use Disorders
1
General
1
Research & Development
1
Best Practice
1
Context & Facts, Travel Advice
1
Public Health
1
Faith-based Organizations
1
Clinical Guidelines
1
Human Rights
1
Scientific & Research Studies
1
Information for the Public
1
Gender Aspects
1
Workplace
1
General Background
1
Hospital Readiness/Essential Health Services
1
Blood Supply
1
Tips & Best Practice Examples
1
Community Health
1
Vaccine Candidates & Research
1
Non-pharmaceutical interventions (NPIs)
1
Ebola Treatment Center
1
Psychosocial Support
1
Biontech/Pfizer Comirnaty
1
Sputnik V
1
Covaxin
1
Research & Pipeline
1
Inactivated COVID-19 Vaccines
1
Hygiene
1
Sanitation
1
Handbooks & Manuals
1
Self-care
1
Primary Care
1
Studies & Reports
1
Midwives
1
Nurses
1
Palliative Care
1
Advocacy & Communication
1
Guidelines General
1
Planetary Health
1
Green & healthy living
1
Pediatrics
1
Guiding documents and principles
1
Freshwater use
1
Pharmaceutical Dosage Forms
1
Resource Platforms
1
Capacity Building
1
Ukraine
1
Zoonoses
1
Infectious Diseases
1
Ethics
1
Water Pollution
1
Nuclear & Chemical Hazards
1
Emergency health kits
1
Emergency health kits
1
Waste management
1
Global Impact of war
1
Studies & Reports
1
Strategies & Roadmaps
1
Studies & Reports
1
Clinical Aspects & Diagnosis
1
Studies & Reports
1
Prevention & Strategies
1
Clinical Aspects & Diagnosis
1
Studies & Reports
1
Prevention & Strategies
1
Global Overview
1
others
1
Situation Reports & Updates
1
Technical Information
1
Community Worker
1
Assessment & Response
1
Malawi
1
One Health
1
TB/HIV Global
1
Uganda
1
Understanding Global Health
1
Clinical Guidelines
1
General Public
1
TB/HIV Coinfection
1
Clinical Guidelines
1
HIV service delivery
1
Community-based Mental Health Care
1
Learning Disabilities
1
South-east Asia Region
1
Reports & Studies Children HIV
1
HIV in Key Populations
1
Preparedness & Prevention
1
Depression
1
AMR
1
Universal Health Coverage & Primary Health Care
1
Risk Communication & Community Engagement
1
The National pharmaceutical policy aligns itself to the Government vision for development of the health sector, as defined in Vision 2020, the Millennium Development Goals and the Economic Development for Poverty Reduction Strategy and the National Health Policy. The pharmacy policy addresses, among...
Every day, fake medicines and medical products are sold at street corners, in open air markets or on unregulated websites in several countries in the African Region. These poor quality, unsafe medicines and pharmaceutical products promote drug resistance and lead to loss of confidence in health prof...
Session V: Regulatory & quality assurance aspects
Update on prequalification of ARVs and regional harmonisation of medicine registration
Deusdedit K. Mubangizi
Group Lead, Inspections, WHO-PQT E-mail: mubangizid@who.int
Acknowledgements:
• Matthias Stahl
• Milan Smid
• Antony Fake
...
These guidelines have been developed to provide guidance to the Ministry of Health in managing applications for registration of human pharmaceutical products in Rwanda. It was compiled by the Technical Working Group (TWG) on Medicines Evaluation and Registration (MER) of the East African Community M...
PQM conducted an assessment of the medicine quality assurance and quality control systems in Rwanda during November 9-13, 2009. Medicine quality assurance remains to be developed in Rwanda: the country has neither a medicine regulatory authority (MRA) nor a national medicine quality control laborato...
Medicines and Allied Substances [No. 3 of 2013 47 | An Act to continue the existence of the Pharmaceutical Regulatory Authority and re-name it as the Zambia Medicines Regulatory Authority; provide for the functions and powers of the Authority; provide for the registration and regulation of pharmacie...
This document provides additional guidance for the responsible and prudent use of antimicrobials in food-producing animals, and should be read in conjunction with the Recommended International Code of Practice for Control of the Use of Veterinary Drugs CAC/RCP 38-1993. Its obj...
Taking the whole of Africa approach to fighting the COVID-19 pandemic has and will continue to require coordinated efforts from multiple stakeholders from across the continent. Africa CDC would like to acknowledge the deep partnership and continued support of AUDA-NEPAD, AVAREF, WHO AFRO, the Bill a...
Licensed pharmaceutical products (marketing authorization) should be manufactured only by licensed manufacturers (holders of a manufacturing authorization) whose activities are regularly inspected by competent national authorities. This guide to GMP shall be used as a standard to justify GMP status,...
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically assist national medicines regulatory authorities to...
Pharmadex is a web-based tool that helps streamline and track medicines registration for a national drug regulatory authority. This tool was created by the USAID-funded Systems for Improved Access to Pharmaceutical and Services (SIAPS) Program implemented by Management Sciences for Health
This Pharmaceutical Country Profile for Kenya (2010) has been developed by the Ministry of Medical Services with support of the World Health Organization. The Profile contains information on existing socio-economic and health-related conditions, resources, regulatory structures and processes and out...
Good Manufacturing Practice (GMP) describes a set of principles and procedures that, when followed, ensure that medicines and related substances are of high quality, safety and efficacy. SAHPRA is a
participating authority of the Pharmaceutical Inspection Cooperation Scheme (jointly known as PIC/S)...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
